[A tumor sensitivity test, SDI test using XTT].
Kondo
T
T
Tokai Central Hospital, Dept. of Surgery, Kakamigahara, Japan.
Tatematsu
A
A
Sato
Y
Y
Ishikawa
M
M
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology; D002286:Carcinoma, Ehrlich Tumor / Q000473:pathology; D004354:Drug Screening Assays, Antitumor / Q000379:methods; D051379:Mice; D008815:Mice, Inbred Strains; D012510:Sarcoma 180 / Q000473:pathology; D013385:Succinate Dehydrogenase / Q000037:antagonists & inhibitors*; D013778:Tetrazolium Salts; D013844:Thiazoles; D014407:Tumor Cells, Cultured / Q000187:drug effects / Q000473:pathology
D000970:Antineoplastic Agents; D013778:Tetrazolium Salts; D013844:Thiazoles; C059087:2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2H-tetrazolium hydroxide; D013385:Succinate Dehydrogenase; C022616:thiazolyl blue